A better surgical resectability of WHO grade II gliomas is independent of favorable molecular markers
- 28 September 2014
- journal article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 121 (1), 185-193
- https://doi.org/10.1007/s11060-014-1623-y
Abstract
A higher extent of resection (EOR) in WHO grade II gliomas (GIIG) is correlated with longer survival. However, the molecular markers also feature prognostic relevance. Here, we examined whether maximal EOR was related to the genetic profile. We retrospectively investigated the predictive value of 1p19q, IDH1, 53 expression and Ki67 index for the EOR in 200 consecutive GIIGs (2007-2013). Data were modeled in a linear model. The analysis was performed with two statistical methods (arcsin-sqrt and Beta-regression model with logit link). There was no deletion 1p19q in 118 cases, codeletion 1p19q (57 cases), single deletion 1p (4 cases) or19q (16 cases). 155 patients had a mutation of IDH1. p53 was graded in 4 degrees (0:92 cases, 1:52 cases, 2:31 cases, 3:8 cases). Mean Ki67 index was 5.2 % (range 1-20 %). Mean preoperative tumor volume was 60.8 cm(3) (range 3.3-250 cm(3)) and mean EOR was 0.917 (range 0.574-1). The statistical analysis was significant for a lower EOR in patients with codeletion 1p19q (OR 0.738, p = 0.0463) and with a single deletion 19q (OR 0.641, p = 0.0168). There was no significant correlation between IDH1 or p53 and the EOR. Higher Ki67 was marginally associated with higher EOR (p = 0.0603). The study demonstrates in a large cohort of GIIG that a higher EOR is not attributable to favorable genetic markers. This original result supports maximal surgical resection as an important therapeutic factor per se to optimize prognosis, independently of the molecular pattern.Keywords
This publication has 39 references indexed in Scilit:
- Supratentorial Gliomas in Eloquent Areas: Which Parameters Can Predict Functional Outcome and Extent of Resection?PLOS ONE, 2013
- IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survivalNeuro-Oncology, 2013
- Plastic relocation of motor cortex in a patient with LGG (low grade glioma) confirmed by NBS (navigated brain stimulation)Acta Neurochirurgica, 2012
- IDH Mutations in Human GliomaNeurosurgery Clinics of North America, 2012
- The challenge to remove diffuse low-grade gliomas while preserving brain functionsActa Neurochirurgica, 2012
- Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological studyNeuro-Oncology, 2011
- Validation of EORTC Prognostic Factors for Adults With Low-Grade Glioma: A Report Using Intergroup 86-72-51International Journal of Radiation Oncology*Biology*Physics, 2011
- Molecular Classification of Low-Grade Diffuse GliomasThe American Journal of Pathology, 2010
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- p53 protein accumulation and gene mutations in human glioma cell linesInternational Journal of Cancer, 1993